Prostate Cancer Research: Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?

« In King's death, a lesson in ovarian cancer's deadliness | Main | In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein. »

Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?

Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?
Related Articles Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer? Nat Clin Pract Oncol. 2005 Feb;2(2):70-1 Authors: Sleijfer S, Stoter G PMID: 16264874 [PubMed - indexed for MEDLINE]

Posted by blogposter on February 27, 2006 08:29 PM | Permalink

Prostate Cancer Research

A blog devoted to surviving prostate cancer, finding treatment options, new drug therapies and new clinical trials. We cover the very latest research.

Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?